Information
                
                    - 
                        
 Trademark
                     
                    - 
                        
 99148525
                     
                
             
         
    
    
    
    
        
            
                - 
                                
International Classifications
                                
                 
            
         
     
    
        
            
                - 
                    
Filing Date
                    April 22, 2025
                    6 months ago
                 
                    - 
                        
Transaction Date
                        April 23, 2025
                        6 months ago
                     
                    - 
                        
Status Date
                        April 22, 2025
                        6 months ago
                     
                                                                                            
         
     
    
        
            
                - 
                    
Status Code
                    630
                 
                - 
                                    
 
                - 
                        
Attorney Docket Number
                        091151-1690
                                            Attorney Name
                        Tricia L. Schulz
                                     
                - 
                            
Owners
                            
                 
            
         
     
        
     
    
        
        
    
        
        
                Mark Drawing Code
                4
                            Mark Identification
                CHARGE THERAPEUTICS
         
                Case File Statements
                
                        - GS0051: Biopharmaceutical preparations for the treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Pharmaceutical preparations for the prevention of mitochondrial, cardiovascular, renal, ophthalmic, neurologic and metabolic diseases and disorders; Biological preparations for the treatment of cellular abnormalities
 
                        - GS0421: Scientific research and development; biopharmaceutical research, development and testing; Medical and scientific research in the field of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic systems
 
                
                Case File Event Statements
                
                        - 
                            
4/22/2025 - 6 months ago
                            1 - NEW APPLICATION ENTERED
                                                            Type: NWAP
                         
                        - 
                            
4/22/2025 - 6 months ago
                            2 - APPLICATION FILING RECEIPT MAILED
                                                            Type: MAFR